Med School Audio - Medical Knowledge Reimagined & Learning Made Memorable.

Clinical Deep Dives

Health EN ↓ 757 episodes

Clinical Deep Dives is a Medlock Holmes podcast for clinicians and learners who want understanding, not just information. Using classic medical and surgical texts as a guide and the generative power of AI, each episode explores ideas with curiosity and clarity, designed for learning on the move and knowledge that actually sticks. drmanaankarray.substack.com

Be sure to visit the podcast's website and support the creator: drmanaankarray.substack.com

Author

Med School Audio - Medical Knowledge Reimagined & Learning Made Memorable.

Category

Health

Podcast website

drmanaankarray.substack.com

Latest episode

Nov 20, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Pharma 29: Heart Failure - Supporting the Failing Pump 02.02.2026

This episode reframes heart failure as a syndrome of maladaptive compensation . What begins as the body’s attempt to preserve perfusion—fluid retention, vasoconstriction, neurohormonal activation—gradually accelerates damage and inefficiency. We explore heart failure therapy as a coordinated effort to unload the heart, interrupt harmful signals, and restore forward flow over time. When understood...

Pharma 28: Hypertension - Resetting the Pressure Set-Point 02.02.2026

This episode frames hypertension not as a single disease, but as a maladapted regulatory state . Blood pressure is tightly defended by overlapping neural, hormonal, renal, and vascular mechanisms; when elevated chronically, it reflects a shifted set-point rather than simple excess force. We explore antihypertensive therapy as the art of nudging multiple control systems back toward balance—slowly,...

Pharma 27: Ischaemic Heart Disease - Matching Supply to Demand 02.02.2026

This episode frames ischaemic heart disease as a problem of mismatch : myocardial oxygen demand exceeding supply. Rather than focusing on individual drugs, we build a physiological map of coronary flow, preload, afterload, heart rate, and contractility—and then show how anti-anginal therapies act by reshaping these variables. When understood this way, nitrates, beta-blockers, and calcium channel b...

Pharma 26: Renin–Angiotensin - Governing Pressure and Perfusion 02.02.2026

This episode explores the renin–angiotensin system as a master regulator of blood pressure, volume, and organ perfusion. Designed to protect circulation during threat, this system becomes harmful when chronically activated. We trace the pathway from renal sensing to vascular tone and aldosterone release, then show how antihypertensive drugs intervene at different control points. Understanding the...

Pharma 25: Renal Excretion - Controlling Volume, Pressure, and Balance 02.02.2026

This episode introduces renal pharmacology as a study of flow, filtration, and fine control . The kidney is not just a passive exit route for drugs, but an active regulator of volume, electrolytes, and blood pressure—and therefore a powerful therapeutic lever. By understanding how drugs interact with renal physiology, especially along the nephron, we can make sense of diuretics, fluid shifts, elec...

Pharma 24: Addiction - When Reward Becomes Capture 02.02.2026

This episode reframes addiction as a disorder of learning and salience , not morality or willpower. Drugs of misuse hijack reward pathways, over-assign importance to cues, and remodel circuits that govern impulse, stress, and memory. We trace how repeated exposure converts voluntary use into compulsion, why abstinence alone is fragile, and how pharmacological treatments work by stabilising circuit...

Pharma 23: Ethanol - The Familiar Drug with Unfamiliar Power 02.02.2026

This episode examines ethanol as one of the most widely used—and most underestimated—psychoactive drugs. Alcohol’s effects span neurotransmission, reward, inhibition, and autonomic control, with acute and chronic consequences that differ profoundly. By treating ethanol with the same pharmacological seriousness as any other CNS agent, we uncover why its benefits are transient, its harms cumulative,...

Pharma 22: Local Anaesthetics - Silencing Pain at the Source 02.02.2026

This episode focuses on local anaesthetics as tools of precision. Rather than altering awareness, these agents selectively block pain transmission by stabilising excitable membranes at the site of action. We explore how sodium channel blockade translates into predictable sensory loss, why different fibres fall silent at different rates, and how anatomy, dose, and delivery determine both efficacy a...

Pharma 21: General Anaesthetics - Consciousness, Control, and Letting Go 02.02.2026

This episode explores general anaesthetics as agents that reorganise consciousness rather than simply induce sleep. We examine how anaesthesia alters perception, memory, movement, and autonomic control in a coordinated way that allows surgery to occur without suffering. By focusing on shared principles—network suppression, disconnection, and reversibility—we make sense of diverse agents, delivery...

Pharma 20: Opioids and Pain - Relief, Risk, and Responsibility 02.02.2026

This episode examines opioids not simply as analgesics, but as powerful modifiers of how pain is experienced , interpreted, and remembered. We explore pain as a multidimensional phenomenon—sensory, emotional, and cognitive—and show how opioids act across these layers. Framed this way, both their unmatched clinical value and their capacity for harm become understandable, predictable, and ethically...

Pharma 19: Hypnotics and Sedatives - Calming the Overactive Brain 02.02.2026

This episode explores hypnotics and sedatives as agents that lower arousal thresholds rather than induce unconsciousness. We examine how these drugs interact with inhibitory systems—particularly GABAergic signalling—to quiet hyperactive networks, facilitate sleep, and reduce anxiety. Framed this way, their benefits and risks become predictable: sedation, amnesia, tolerance, and dependence all foll...

Pharma 18: Neurodegeneration - Slowing the Unravelling 01.02.2026

This episode examines drugs used in central nervous system degenerative disorders through a lens of preservation rather than reversal. Conditions such as Parkinson’s disease, Alzheimer’s disease, and related syndromes reflect progressive loss of neurons and network integrity. Pharmacology here is about buying time, restoring functional balance, and reducing downstream harm. We focus on why benefit...

Pharma 17: Epilepsy - Containing the Electrical Storm 01.02.2026

Episode description (with key takeaways) This episode explores antiseizure pharmacology as the art of stabilising excitable networks. Seizures arise when synchronous firing overwhelms inhibitory control; treatment therefore focuses on shifting thresholds, damping propagation, and restoring balance between excitation and inhibition. We move beyond drug lists to a small set of governing principles t...

Pharma 16: Psychosis and Mania - Reality, Regulation, and Restraint 01.02.2026

This episode examines the pharmacological treatment of psychosis and mania as an exercise in regulation rather than suppression. Antipsychotics and mood stabilisers act on systems that assign meaning, importance, and momentum to thoughts and experiences. We move beyond dopamine reduction as a slogan to understand why these drugs work, why they take time, and why adverse effects often mirror the sy...

Pharma 15: Treating Depression and Anxiety - Restoring Emotional Balance 01.02.2026

This episode examines the pharmacological treatment of depression and anxiety through the lens of adaptation and balance. Rather than viewing these conditions as simple chemical deficits, we explore how sustained modulation of neurotransmitter systems gradually recalibrates circuits involved in mood, threat perception, sleep, and cognition. The delayed onset of benefit, the prominence of side-effe...

Pharma 14: Neurotransmission in the Central Nervous System 01.02.2026

This episode widens the lens from individual synapses to whole neural networks. Central nervous system neurotransmission is less about linear pathways and more about integration—multiple signals converging, diverging, and being reshaped in real time. We explore how excitation and inhibition are balanced, how plasticity changes responses over time, and why drugs acting in the CNS often have broad,...

Pharma 13: Serotonin and Dopamine - Mood, Motion, and Meaning 01.02.2026

Episode description (with key takeaways) This episode explores serotonin and dopamine as systems of context rather than single functions. Together, they influence mood, motivation, reward, perception, and movement. We move past simplistic labels (“happy chemical”, “pleasure pathway”) to understand distributed circuits, receptor diversity, and downstream consequences. This framework explains why dr...

Pharma 12: Adrenergic Signalling - Speed, Strength, and Selectivity 01.02.2026

This is a free preview of a paid episode. To hear more, visit drmanaankarray.substack.com Episode description (with key takeaways) This episode explores adrenergic pharmacology as the language of speed and force in human physiology. Adrenaline and noradrenaline drive rapid cardiovascular, respiratory, and metabolic adjustments, preparing the body for demand. We move beyond memorising α and β recep...

Pharma 11: Nicotinic Signalling - Junctions, Gates, and Thresholds 31.01.2026

This episode examines nicotinic receptor pharmacology at two critical crossroads: autonomic ganglia and the neuromuscular junction. Here, signalling is rapid, decisive, and threshold-dependent—very different from the modulatory tone of muscarinic systems. We explore how drugs that act at nicotinic receptors can stimulate, block, or exhaust transmission, and why small shifts at these junctions can...

Pharma 10: Anticholinesterase Agents - Prolonging the Signal 31.01.2026

This episode focuses on anticholinesterase agents as a distinctive pharmacological strategy: rather than stimulating receptors directly, these drugs extend the life of an endogenous signal. By inhibiting acetylcholinesterase, they increase acetylcholine availability at synapses and neuromuscular junctions, sharpening or overwhelming physiological effects depending on dose and context. We explore h...

Pharma 09: Muscarinic Signalling - Turning Up and Turning Down 31.01.2026

This episode explores muscarinic receptor pharmacology as a lesson in nuance. Acetylcholine acting at muscarinic receptors governs secretion, smooth muscle tone, heart rate, and central signalling. We move beyond lists of agonists and antagonists to understand muscarinic effects as context-dependent responses shaped by receptor subtype, tissue distribution, and baseline autonomic tone. This framin...

Pharma 08: Neurotransmission - Wiring the Nervous System 31.01.2026

This episode lays the physiological foundation for all of neuropharmacology by exploring how neurons communicate with each other and with effector organs. Rather than starting with drug classes, we begin with the architecture of signalling itself: synapses, neurotransmitters, receptors, and termination mechanisms. Autonomic and somatic systems are contrasted to show how pharmacology exploits norma...

Pharma 07: Pharmacogenetics — Why One Dose Never Fits All 31.01.2026

This episode explores how genetics influences the way individuals handle and respond to medicines. Pharmacogenetics is framed not as a futuristic add-on, but as an extension of everyday pharmacology—explaining why standard doses fail some patients, harm others, and work beautifully for a few. We focus on principles that clinicians can recognise and apply, even when formal genetic testing is unavai...

Pharma 06: Drug Metabolism - Transformation and Consequence 31.01.2026

This episode looks at what happens when a drug meets the body’s chemical processing plants. Drug metabolism is framed not as simple breakdown, but as biotransformation —a set of enzymatic decisions that can inactivate drugs, activate pro-drugs, generate toxic intermediates, or change duration of action. We explore why metabolism is central to variability, interactions, and organ-specific risk, and...

Pharma 05: Membrane Transporters and Drug Response 31.01.2026

This episode explores a layer of pharmacology that quietly shapes almost every therapeutic decision but is often overlooked: membrane transporters. These proteins act as biological customs officers, controlling drug entry, distribution, and elimination at the cellular level. We examine how transporters influence variability in drug response, underpin many drug–drug interactions, and explain why tw...

Listen to the Clinical Deep Dives podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.